Books on the topic 'Thrombolytic Agent'

To see the other types of publications on this topic, follow the link: Thrombolytic Agent.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Thrombolytic Agent.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Kotb, Essam. Fibrinolytic bacterial enzymes with thrombolytic activity. Heidelberg: Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

A, Mousa Shaker, ed. Anticoagulants, antiplatelets, and thrombolytics. Totowa, N.J: Humana Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Anticoagulants, antiplatelets, and thrombolytics. 2nd ed. New York, NY: Humana, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

1927-, Sasahara Arthur A., and Loscalzo Joseph, eds. New therapeutic agents in thrombosis and thrombolysis. 2nd ed. New York: M. Dekker, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Taylor, George Jesse. Thrombolytic therapy for acute myocardial infarction. Boston: Blackwell Scientific Publications, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

J, Del Zoppo Gregory, Mori Etsuro 1951-, and Hacke W. 1948-, eds. Thrombolytic therapy in acute ischemic stroke II. Berlin: Springer-Verlag, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

C, Becker Richard, ed. The modern era of coronary thrombolysis. Boston: Kluwer Academic Publishers, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Morganroth, Joel, and E. Neil Moore, eds. Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4613-1605-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Joel, Morganroth, and Moore E. Neil, eds. Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988. Boston: Kluwer Academic Publishers, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Antithrombotic drug therapy in cardiovascular disease. Dordrecht: Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Fibrinolysis, thrombosis, and hemostasis: Concepts, perspectives, and clinical applications. Philadelphia: Lea & Febiger, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Antithrombotic drugs in thrombosis models. Boca Raton, Fla: CRC Press, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Wellcome Trust. Centre for the History of Medicine at UCL, ed. The recent history of platelets in thrombosis and other disorders: The transcript of a Witness seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 25 November 2003. London: Wellcome Trust Centre for the History of Medicine, University College London, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Becker, Richard C. Fibrinolytic and antithrombotic therapy: Theory, practice, and management. 2nd ed. New York, NY: Oxford University Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Becker, Richard C. Fibrinolytic and antithrombotic therapy: Theory, practice, and management. 2nd ed. New York: Oxford University Press, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Askari, Arman. Management strategies in antithrombotic therapy. Chichester: John Wiley and Sons, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

A, Nienaber Christoph, and Sechtem Udo, eds. Imaging and intervention in cardiology. Dordrecht: Kluwer Academic Publishers, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

D, Collen, Lijnen H. R, and Verstraete M, eds. Thrombolysis: Biological and therapeutic properties of new thrombolytic agents. Edinburgh: Churchill Livingstone, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Verstraete, M., Desire Collen, and H. R. Lijnen. Thrombolysis: Biological and Therapeutic Properties of New Thrombolytic Agents (CIHT). Churchill Livingstone, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Mayor, Diana, and Michael Tymianski. Neuroprotection for Acute Ischemic Stroke. Edited by David L. Reich, Stephan Mayer, and Suzan Uysal. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190280253.003.0010.

Full text
Abstract:
Acute ischemic stroke (AIS) is the leading cause of acquired neurological disability worldwide. AIS most commonly occurs when a cerebral artery is occluded, leading to irreversible brain injury and neurologic disability. Acute supportive physiological interventions and close monitoring on a stroke unit are beneficial to optimize overall recovery and functional outcome. Phamacological treatment options are limited though as the only FDA-approved therapy for AIS is the thrombolytic agent intravenous recombinant tissue plasminogen activator (Alteplase, rtPA), which improves functional outcome in therapeutic time windows ranging up to 3–4.5 hours. Several clinical trials assessing the efficacy of endovascular therapy have shown a benefit in carefully selected patients with a documented large vessel occlusion (LVO), and subsequently are becoming part of the standard practice in this AIS subset. Clinical trials using various imaging paradigms to enhance patient selection for thrombolytic therapy, endovascular therapy and neuroprotection therapies are all progressing.
APA, Harvard, Vancouver, ISO, and other styles
21

J, Comerota Anthony, ed. Thrombolytic therapy. Orlando: Grune & Stratton, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Timmis, Gerald C. Thrombolytic Therapy. Edited by Gerald C. Timmis. Futura Publishing Company, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Kotb, Essam. Fibrinolytic Bacterial Enzymes with Thrombolytic Activity. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Julien, Bogousslavsky, and Hacke W. 1948-, eds. Thrombolytic and antithrombotic therapy for stroke. London: Informa Healthcare, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

(Editor), Julian Bogousslavsky, and Werner Hacke (Editor), eds. Thrombolytic and Antithrombotic Therapy for Stroke. Informa Healthcare, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Bogousslavsky, Julien, and Hacke. Thrombolytic and Antithrombotic Therapy for Stroke. Taylor & Francis Group, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Frost & Sullivan., ed. The U.S. market for anticoagulants & thrombolytics. New York: Frost & Sullivan, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Anticoagulants, antiplatelets, and thrombolytics. Totowa, NJ: Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

A, Mousa Shaker, ed. Anticoagulants, antiplatelets, and thrombolytics. Totowa, N.J: Humana Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

M, Califf Robert, Mark Daniel B, and Wagner Galen S, eds. Acute coronary care in the thrombolytic era. Chicago: Year Book Medical Publishers, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

1927-, Sasahara Arthur A., and Loscalzo Joseph, eds. New therapeutic agents in thrombosis and thrombolysis. New York: M. Dekker, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
32

New Therapeutic Agents in Thrombosis and Thrombolysis. New York: Marcel Dekker, Inc., 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Loscalzo, Joseph, and Jane E. Freedman. New Therapeutic Agents in Thrombosis and Thrombolysis. Taylor & Francis Group, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Loscalzo, Joseph, and Arthur Sasahara. New Therapeutic Agents in Thrombosis and Thrombolysis. Taylor & Francis Group, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

E, Freedman Jane, and Loscalzo Joseph, eds. New therapeutic agents in thrombosis and thrombolysis. 3rd ed. New York: Informa Healthcare USA, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

Loscalzo, Joseph, and Jane E. Freedman. New Therapeutic Agents in Thrombosis and Thrombolysis. Taylor & Francis Group, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Freedman, Jane E., and Joseph Loscalzo, eds. New Therapeutic Agents in Thrombosis and Thrombolysis. CRC Press, 2016. http://dx.doi.org/10.3109/9781420069242.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Lip, Gregory Y. H., and Andrew Blann. ABC of Antithrombotic Therapy. Wiley & Sons, Incorporated, John, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Lip, Gregory Y. H., and Andrew D. Blann. ABC of Antithrombotic Therapy (ABC). Blackwell Publishing Limited, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

(Editor), William R. Bell, Arthur A. Sasahara (Editor), and Tim Phelps (Illustrator), eds. Review of Thrombolytic Therapy and Thromboembolic Disease. Physicians & Scientists Publishing Company, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

1932-, Haber Edgar, Braunwald Eugene 1929-, and National Heart, Lung, and Blood Institute., eds. Thrombolysis: Basic contributions and clinical progress. St. Louis: Mosby-Year Book, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Thrombolytic Therapy in Acute Ischemic Stroke III. Springer, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

(Editor), T. Yamaguchi, Etsuro Mori (Editor), K. Minematsu (Editor), and G. J. Del Zoppo (Editor), eds. Thrombolytic Therapy in Acute Ischemic Stroke III. Springer, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Becker, Richard C. Modern Era of Coronary Thrombolysis. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Becker, Richard C. Modern Era of Coronary Thrombolysis. Springer London, Limited, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

M, Ross Allan, ed. Acute myocardial infarction: Thrombolysis and angioplasty. Dallas, TX: American Heart Association, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

G, Julian Desmond, ed. Thrombolysis in cardiovascular disease. New York: M. Dekker, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

(Editor), Arthur Sasahara, and Joseph Loscalzo (Editor), eds. New Therapeutic Agents in Thrombosis and Thrombolysis, Second Edition, (Fundamental and Clinical Cardiology, V. 46). 2nd ed. Informa Healthcare, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

J, Earnshaw J., and Gregson R. H. S, eds. Practical peripheral arterial thrombolysis. Oxford: Butterworth-Heinemann, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

Mousa, Shaker A. Anticoagulants, Antiplatelets, and Thrombolytics (Methods in Molecular Medicine). Humana Press, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography